Literature Collection

Magnifying Glass
Collection Insights

11K+

References

9K+

Articles

1500+

Grey Literature

4600+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Enter Search Term(s)
Year
Sort by
Order
Show
12252 Results
3063
DATAWATCH: Career flexibility of physician assistants and the potential for more primary care
Type: Journal Article
Authors: Roderick S. Hooker, James F. Cawley, William Leinweber
Year: 2010
Topic(s):
Education & Workforce See topic collection
,
Healthcare Policy See topic collection
3064
DATAWATCH: Choice of specialties among physician assistants in the United States
Type: Journal Article
Authors: Perri A. Morgan, Roderick S. Hooker
Year: 2010
Topic(s):
Education & Workforce See topic collection
3065
DAWN 2022 Non-Fatal Overdoses Short Report
Type: Web Resource
Authors: Drug Abuse Warning Network
Year: 2023
Publication Place: Rockville, MD
Topic(s):
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3066
DEA Announces Important Change to Registration Requirement
Type: Report
Authors: Drug Enforcement Administration
Year: 2023
Publication Place: Springfield, VA
Topic(s):
Healthcare Policy See topic collection
,
Opioids & Substance Use See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3067
DEA Announces Three New Telemedicine Rules that Continue to Open Access to Telehealth Treatment while Protecting Patients
Type: Report
Authors: United States Drug Enforcement Administration
Year: 2025
Publication Place: Arlington, VA
Topic(s):
HIT & Telehealth See topic collection
,
Opioids & Substance Use See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3069
Deaths associated with opioids, race and ethnicity, and years of potential life lost in washington state
Type: Journal Article
Authors: Solmaz Amiri, Christine D. Pham, Samantha Castonguay, Justin T. Denney, Dedra S. Buchwald
Year: 2022
Topic(s):
Healthcare Disparities See topic collection
3070
Deaths from Excessive Alcohol Use — United States, 2016–2021
Type: Web Resource
Authors: Marissa B. Esser, Adam Sherk, Yong Liu, Timothy Naimi
Year: 2024
Publication Place: Washington, D.C.
Topic(s):
Opioids & Substance Use See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3071
Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 - 10 States, July-December 2016
Type: Journal Article
Authors: Julie K. O'Donnell, John Halpin, Christine L. Mattson, Bruce A. Goldberger, Matthew Gladden
Year: 2017
Abstract: Sharp increases in opioid overdose deaths since 2013 are partly explained by the introduction of illicitly manufactured fentanyl into the heroin market. Outbreaks related to fentanyl analogs also have occurred. One fentanyl analog, carfentanil, is estimated to be 10,000 times more potent than morphine. Fentanyl analogs are not routinely detected because specialized toxicology testing is required. This is the first report using toxicologic and death scene evidence across multiple states to characterize opioid overdose deaths. Fentanyl was involved in >50% of opioid overdose deaths, and >50% of deaths testing positive for fentanyl and fentanyl analogs also tested positive for other illicit drugs. Approximately 700 deaths tested positive for fentanyl analogs, with the most common being carfentanil, furanylfentanyl, and acetylfentanyl.
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
3072
Decision memo for screening for depression in adults (CAG-00425N)
Type: Web Resource
Authors: L. Jacques, T. S. Jensen, J. Schafer, S. Caplan, L. Schott
Year: 2011
Publication Place: Baltimore, MD
Topic(s):
Healthcare Policy See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3075
Decisions in Recovery: Treatment for Opioid Use Disorder Handbook
Type: Government Report
Authors: Substance Abuse and Mental Health Services Administration
Year: 2016
Publication Place: Rockville, MD
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3077
Decreased cocaine demand following contingency management treatment
Type: Journal Article
Authors: Jin H. Yoon, Robert Suchting, Constanza de Dios, Jessica N. Vincent, Sarah A. McKay, Scott D. Lane, Joy M. Schmitz
Year: 2021
Topic(s):
Opioids & Substance Use See topic collection
3078
Decreasing Role Strain for Caregivers of Veterans with Dependence in Performing Activities of Daily Living
Type: Journal Article
Authors: Colleen L. Campbell, Sean McCoy, Nannette Hoffman, Patricia O'Neil
Year: 2014
Topic(s):
Education & Workforce See topic collection
,
Medical Home See topic collection
3079
Decreasing Stigma Involving Addiction Begins With the Medical Profession
Type: Web Resource
Authors: Ayana Jordan
Year: 2018
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3080
Deep brain stimulation of the hypothalamic region: a systematic review
Type: Journal Article
Authors: M. Mofatteh, A. Mohamed, M. S. Mashayekhi, G. P. Skandalakis, C. Neudorfer, S. Arfaie, A. MohanaSundaram, M. Sabahi, A. Anand, R. Aboulhosn, X. Liao, A. Horn, K. Ashkan
Year: 2025
Abstract:

BACKGROUND: Deep brain stimulation (DBS) has been successfully used for the treatment of circuitopathies including movement, anxiety, and behavioral disorders. The hypothalamus is a crucial integration center for many peripheral and central pathways relating to cardiovascular, metabolic, and behavioral functions and constitutes a potential target for neuromodulation in treatment-refractory conditions. To conduct a systematic review, investigating hypothalamic targets in DBS, their indications, and the primary clinical findings. METHODS: PubMed, Scopus, and Web of Science databases were searched in accordance with the PRISMA guideline to identify papers published in English studying DBS of the hypothalamus in humans. RESULTS: After screening 3,148 papers, 34 studies consisting of 412 patients published over two decades were included in the final review. Hypothalamic DBS was indicated in refractory headaches (n = 238, 57.8%), aggressive behavior (n = 100, 24.3%), mild Alzheimer's disease (n = 58, 14.1%), trigeminal neuralgia in multiple sclerosis (n = 5, 1.2%), Prader-Willi syndrome (n = 4, 0.97%), and atypical facial pain (n = 3, 0.73%). The posterior hypothalamus was the most common DBS target site across 30 studies (88.2%). 262 (63.6%) participants were males, and 110 (26.7%) were females. 303 (73.5%) patients were adults whereas 33 (8.0%) were pediatrics. The lowest mean age of participants was 15.25 ± 4.6 years for chronic refractory aggressiveness, and the highest was 68.5 ± 7.9 years in Alzheimer's disease patients. The mean duration of the disease ranged from 2.2 ± 1.7 (mild Alzheimer's disease) to 19.8 ± 10.1 years (refractory headaches). 213 (51.7%) patients across 29 studies (85.3%) reported symptom improvements which ranged from 23.1% to 100%. 25 (73.5%) studies reported complications, most of which were associated with higher voltage stimulations. CONCLUSIONS: DBS of the hypothalamus is feasible in selected patients with various refractory conditions ranging from headaches to aggression in both pediatric and adult populations. Future large-scale studies with long-term follow-up are required to validate the safety and efficacy data and extend these findings.

Topic(s):
General Literature See topic collection